Description
P3.13 Plerixafor in autologous haematopoietic stem cell mobilization in Belgium
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: P3.13 Plerixafor in autologous haematopoietic stem cell mobilization in Belgium
€3.03
Related products
-
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Highlights in melanoma
€3.03 Add to cart
Reviews
There are no reviews yet.